25 May 2013
Keywords: british, biotech, gets, boost, s-p, signs, mmpi
Article | 08 September 1999
After publishing promising data from a Phase III trial of its matrixmetalloproteinase inhibitor marimastat for the treatment of gastric
cancer ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 September 1999
9 September 1999
24 May 2013
© 2013 thepharmaletter.com